Bank of America Securities analyst Alec Stranahan reiterated a Buy rating on Meiragtx Holdings (MGTX – Research Report) today and set a price ...

BofA analyst Alec Stranahan raised the firm’s price target on MeiraGTx (MGTX) to $14 from $12 and keeps a Buy rating on the shares, citing a ...

Shares of MeiraGTx Holdings (NASDAQ:MGTX) traded higher in the premarket on Thursday after the company, with its Q4 2024 results, announced an agreement with AI-focused research firm Hologen Limited ...

MeiraGTx (NASDAQ:MGTX – Get Free Report) will likely be releasing its earnings data before the market opens on Thursday, ...

Today announced strategic collaboration with Hologen AI, including a $200 million upfront payment to MeiraGTx and the formation of a joint venture, Hologen Neuro AI Ltd, with a further $230 million in ...

MeiraGTx and Hologen form a neuro-AI drug development joint venture, with up to $430M in funding to advance Parkinson's and CNS treatments.

MeiraGTx (Nasdaq: MGTX) has entered into a strategic partnership with artificial intelligence firm Hologen to accelerate the ...

Investing.com -- Shares of MeiraGTx Holdings plc (Nasdaq: NASDAQ: MGTX) climbed 13% following the announcement of a strategic collaboration with Hologen AI, aimed at accelerating the Phase 3 ...

In this article, we are going to take a look at where MeiraGTx Holdings plc (NASDAQ:MGTX) stands against other Billionaire Joseph Edelman’s long-term stock picks. Joseph Edelman is a renowned ...

In this article, we are going to take a look at where MeiraGTx Holdings plc (NASDAQ:MGTX) stands against the other gene therapy stocks. Gene therapy is referred to as a medical technique that ...

It reported third-quarter adjusted sales of $689.445 million, according to Benzinga Pro. Avi Kapoor MGTX Stock Up on Upbeat Efficacy Data From Parkinson's Disease Study MeiraGTx Holdings' (NASDAQ ...